Cargando…

Survivin as a Prognostic Factor for Osteosarcoma Patients

Purpose: Survivin is one of the apoptosis inhibitor genes and is rarely expressed in adult ­tissues. However, survivin expression has been detected in various human cancers and ­correlations have been recognized between the level of expression of this gene in tumors and prognosis. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Osaka, Eiji, Suzuki, Takashi, Osaka, Shunzo, Yoshida, Yukihiro, Sugita, Hideyuki, Asami, Satoru, Tabata, Keiichi, Hemmi, Akihiro, Sugitani, Masahiko, Nemoto, Norimichi, Ryu, Junnosuke
Formato: Texto
Lenguaje:English
Publicado: Japan Society of Histochemistry and Cytochemistry 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790971/
https://www.ncbi.nlm.nih.gov/pubmed/17327929
http://dx.doi.org/10.1267/ahc.06005
_version_ 1782132141212041216
author Osaka, Eiji
Suzuki, Takashi
Osaka, Shunzo
Yoshida, Yukihiro
Sugita, Hideyuki
Asami, Satoru
Tabata, Keiichi
Hemmi, Akihiro
Sugitani, Masahiko
Nemoto, Norimichi
Ryu, Junnosuke
author_facet Osaka, Eiji
Suzuki, Takashi
Osaka, Shunzo
Yoshida, Yukihiro
Sugita, Hideyuki
Asami, Satoru
Tabata, Keiichi
Hemmi, Akihiro
Sugitani, Masahiko
Nemoto, Norimichi
Ryu, Junnosuke
author_sort Osaka, Eiji
collection PubMed
description Purpose: Survivin is one of the apoptosis inhibitor genes and is rarely expressed in adult ­tissues. However, survivin expression has been detected in various human cancers and ­correlations have been recognized between the level of expression of this gene in tumors and prognosis. In this study, we investigated the correlations between survivin mRNA expres­sion in osteosarcoma tissues and clinicopathological parameters. Methods: There were 22 osteosarcoma patients in our hospital with paraffin-embedded ­tissues which could be extracted from biopsy specimens. We used the RT-PCR method after extracting total RNA and conducted a densitometric analysis to determine the ratio of survivin relative to h-GAPDH as an internal marker. Results: Expression of survivin mRNA was detected in all osteosarcoma samples. Patients with metastasis had high survivin mRNA levels in initial biopsy specimens (p<0.01). Moreover, there was a statistically significant difference in survivin mRNA expression between ­patients with and without metastasis (p<0.01). Conclusion: We concluded that high levels of survivin mRNA expression suggest poor prognosis for osteosarcoma patients.
format Text
id pubmed-1790971
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Japan Society of Histochemistry and Cytochemistry
record_format MEDLINE/PubMed
spelling pubmed-17909712007-02-27 Survivin as a Prognostic Factor for Osteosarcoma Patients Osaka, Eiji Suzuki, Takashi Osaka, Shunzo Yoshida, Yukihiro Sugita, Hideyuki Asami, Satoru Tabata, Keiichi Hemmi, Akihiro Sugitani, Masahiko Nemoto, Norimichi Ryu, Junnosuke Acta Histochem Cytochem Regular Article Purpose: Survivin is one of the apoptosis inhibitor genes and is rarely expressed in adult ­tissues. However, survivin expression has been detected in various human cancers and ­correlations have been recognized between the level of expression of this gene in tumors and prognosis. In this study, we investigated the correlations between survivin mRNA expres­sion in osteosarcoma tissues and clinicopathological parameters. Methods: There were 22 osteosarcoma patients in our hospital with paraffin-embedded ­tissues which could be extracted from biopsy specimens. We used the RT-PCR method after extracting total RNA and conducted a densitometric analysis to determine the ratio of survivin relative to h-GAPDH as an internal marker. Results: Expression of survivin mRNA was detected in all osteosarcoma samples. Patients with metastasis had high survivin mRNA levels in initial biopsy specimens (p<0.01). Moreover, there was a statistically significant difference in survivin mRNA expression between ­patients with and without metastasis (p<0.01). Conclusion: We concluded that high levels of survivin mRNA expression suggest poor prognosis for osteosarcoma patients. Japan Society of Histochemistry and Cytochemistry 2006-07-01 2006-05-26 /pmc/articles/PMC1790971/ /pubmed/17327929 http://dx.doi.org/10.1267/ahc.06005 Text en Copyright © 2006 AHC This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Regular Article
Osaka, Eiji
Suzuki, Takashi
Osaka, Shunzo
Yoshida, Yukihiro
Sugita, Hideyuki
Asami, Satoru
Tabata, Keiichi
Hemmi, Akihiro
Sugitani, Masahiko
Nemoto, Norimichi
Ryu, Junnosuke
Survivin as a Prognostic Factor for Osteosarcoma Patients
title Survivin as a Prognostic Factor for Osteosarcoma Patients
title_full Survivin as a Prognostic Factor for Osteosarcoma Patients
title_fullStr Survivin as a Prognostic Factor for Osteosarcoma Patients
title_full_unstemmed Survivin as a Prognostic Factor for Osteosarcoma Patients
title_short Survivin as a Prognostic Factor for Osteosarcoma Patients
title_sort survivin as a prognostic factor for osteosarcoma patients
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790971/
https://www.ncbi.nlm.nih.gov/pubmed/17327929
http://dx.doi.org/10.1267/ahc.06005
work_keys_str_mv AT osakaeiji survivinasaprognosticfactorforosteosarcomapatients
AT suzukitakashi survivinasaprognosticfactorforosteosarcomapatients
AT osakashunzo survivinasaprognosticfactorforosteosarcomapatients
AT yoshidayukihiro survivinasaprognosticfactorforosteosarcomapatients
AT sugitahideyuki survivinasaprognosticfactorforosteosarcomapatients
AT asamisatoru survivinasaprognosticfactorforosteosarcomapatients
AT tabatakeiichi survivinasaprognosticfactorforosteosarcomapatients
AT hemmiakihiro survivinasaprognosticfactorforosteosarcomapatients
AT sugitanimasahiko survivinasaprognosticfactorforosteosarcomapatients
AT nemotonorimichi survivinasaprognosticfactorforosteosarcomapatients
AT ryujunnosuke survivinasaprognosticfactorforosteosarcomapatients